Stoke Therapeutics
STOK
STOK
93 hedge funds and large institutions have $2.39B invested in Stoke Therapeutics in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
6% more funds holding
Funds holding: 88 → 93 (+5)
3.25% more ownership
Funds ownership: 104.19% → 107.44% (+3.2%)
Holders
93
Holding in Top 10
3
Calls
$4.78M
Puts
$507K
Top Buyers
| 1 | +$103M | |
| 2 | +$29M | |
| 3 | +$26.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.5M |
| 5 |
ALSV
ATP Life Science Ventures
New York
|
+$23.2M |
Top Sellers
| 1 | -$6.19M | |
| 2 | -$4.65M | |
| 3 | -$4.34M | |
| 4 |
Aviva
London,
United Kingdom
|
-$1.84M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.83M |